The HIV/AIDS vaccine researchers' orientation to the process of preparing a US FDA application for an investigational new drug (IND): what it is all about and how you start by preparing for your pre-IND meeting

Author： Shapiro S.Z.  

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.20, Iss.9, 2002-01, pp. : 1261-1280

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Toward a New Communications Framework for HIV/AIDS

By Airhihenbuwa Collins O.   Makinwa Bunmi   Obregon Rafael  

Journal of Health Communication, Vol. 5, Iss. 1, 2000-06 ,pp. : 101-111

Taylor & Francis Ltd

Access to resources Recommend Favorite

Private demand for a HIV/AIDS vaccine: evidence from Guadalajara, Mexico

By Whittington D.   Matsui-Santana O.   Freiberger J.J.   Van Houtven G.   Pattanayak S.  

Vaccine, Vol. 20, Iss. 19, 2002-06 ,pp. : 2585-2591

Elsevier

Access to resources Recommend Favorite

US FDA Drug Classification System

By Johnson Alan J.  

Disease Management & Health Outcomes, Vol. 13, Iss. 5, 2005-01 ,pp. : 355-355

Adis International

Access to resources Recommend Favorite

Nanoparticulate drug carriers for delivery of HIV/AIDS therapy to viral reservoir sites

By Vyas Tushar K   Shah Lipa   Amiji Mansoor M  

Expert Opinion on Drug Delivery, Vol. 3, Iss. 5, 2006-09 ,pp. : 613-628

Informa Healthcare

Access to resources Recommend Favorite

Synthetic AIDS vaccine by targeting HIV receptor

By Wang C.Y.   Shen M.   Tam G.   Fang X.D.   Ye J.   Shen F.   Walfield A.M.   Wang J.J.G.   Li M.L.   Li X.M.   Salas M.   Shearer M.H.   Kennedy R.C.   Hanson C.V.  

Vaccine, Vol. 21, Iss. 1, 2002-11 ,pp. : 89-97

Elsevier

Access to resources Recommend Favorite